Ann Dermatol.  2012 Nov;24(4):486-487. 10.5021/ad.2012.24.4.486.

Nodular Basal Cell Carcinoma Successfully Treated with Intralesional 5-Aminolevulinic Acid Injection-Photodynamic Therapy

• Kim SK
• Shin J
• Kim YC

• KMID: 2266053
• DOI: http://doi.org/10.5021/ad.2012.24.4.486

Abstract

No abstract available.

MeSH Terms

Carcinoma, Basal Cell

Figure

• 

  Fig. 1 (a) A brownish papule on the right side of the nose before photodynamic therapy, (b) resolution of the skin lesion after 5 sessions of treatment.

• 

  Fig. 2 (a) Atypical basaloid tumor cells extending into the mid-dermis, the tumor thickness measuring 1.3 mm (H&E, ×100), (b) after 5 sessions of treatment, no tumor cell is seen (H&E, ×100).

Reference

1. Morton CA, McKenna KE, Rhodes LE. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008. 159:1245–1266.

2. Park MY, Kim YC. Classic Kaposi sarcoma treated with intralesional 5-aminolevulinic acid injection photodynamic therapy. Arch Dermatol. 2009. 145:1200–1202.

3. Sotiriou E, Apalla Z, Ioannides D. Complete resolution of a squamous cell carcinoma of the skin using intralesional 5-aminolevulinic acid photodynamic therapy intralesional PDT for SCC. Photodermatol Photoimmunol Photomed. 2010. 26:269–271.

4. Cappugi P, Mavilia L, Campolmi P, Reali EF, Mori M, Rossi R. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid. J Chemother. 2004. 16:491–493.

5. Gerritsen MJ, Smits T, Kleinpenning MM, van de Kerkhof PC, van Erp PE. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology. 2009. 218:193–202.